Finanzas: Bayer eyes sale of $1.1B dermatology business


Monsanto (MON +1.3%) moves higher following a Bloomberg report that Bayer (OTCPK:BAYRY) is exploring the sale of its dermatology business, as the German company seeks to sell peripheral businesses to boost its pursuit of MON.

The business could attract interest from existing makers of skincare products such as Nestle’s (OTCPK:NSRGY, OTCPK:NSRGF) Galderma, Allergan (NYSE:AGN) and Almirall (OTC:LBTSF) of Spain, as well as P-E firms, according to the report.


LEA TAMBIÉN: Finanzas: Colgate-Palmolive declares $0.39 dividend

Analysts say a sale of the unit could fetch more than €1B ($1.1B).

Fuente: Seeking Alpha

Reciba las últimas noticias de la industria en su casilla:

Suscribirse ✉


Please enter your comment!
Please enter your name here